Literature DB >> 29463596

Rest Easy with Intravenous Iron for Dialysis Patients? High Dose IV Iron Safety.

Xiaojuan Li1, Abhijit V Kshirsagar2.   

Abstract

Entities:  

Keywords:  Cation Transport Proteins; Hematinics; Hepcidins; Intestinal Absorption; Iron; Iron Metabolism Disorders; anemia; metal transporting protein 1; nephrology; renal dialysis

Mesh：

Substances：

Year:  2018        PMID： 29463596      PMCID： PMC5967661          DOI： 10.2215/CJN.00930118

Source DB:  PubMed          Journal:  Clin J Am Soc Nephrol        ISSN： 1555-9041            Impact factor:   8.237


× No keyword cloud information.
  9 in total

Review 1.  Forging a field: the golden age of iron biology.

Authors:  Nancy C Andrews
Journal:  Blood       Date:  2008-07-15       Impact factor: 22.113

2.  Iron management in chronic kidney disease: conclusions from a "Kidney Disease: Improving Global Outcomes" (KDIGO) Controversies Conference.

Authors:  Iain C Macdougall; Andreas J Bircher; Kai-Uwe Eckardt; Gregorio T Obrador; Carol A Pollock; Peter Stenvinkel; Dorine W Swinkels; Christoph Wanner; Günter Weiss; Glenn M Chertow
Journal:  Kidney Int       Date:  2016-01       Impact factor: 10.612

Review 3.  Why sources of heterogeneity in meta-analysis should be investigated.

Authors:  S G Thompson
Journal:  BMJ       Date:  1994-11-19

4.  Safety of Intravenous Iron in Dialysis: A Systematic Review and Meta-Analysis.

Authors:  Ingrid Hougen; David Collister; Mathieu Bourrier; Thomas Ferguson; Laura Hochheim; Paul Komenda; Claudio Rigatto; Navdeep Tangri
Journal:  Clin J Am Soc Nephrol       Date:  2018-02-20       Impact factor: 8.237

5.  Comparative Short-term Safety of Sodium Ferric Gluconate Versus Iron Sucrose in Hemodialysis Patients.

Authors:  M Alan Brookhart; Janet K Freburger; Alan R Ellis; Wolfgang C Winkelmayer; Lily Wang; Abhijit V Kshirsagar
Journal:  Am J Kidney Dis       Date:  2015-09-16       Impact factor: 8.860

6.  Comparative Risk of Anaphylactic Reactions Associated With Intravenous Iron Products.

Authors:  Cunlin Wang; David J Graham; Robert C Kane; Diqiong Xie; Michael Wernecke; Mark Levenson; Thomas E MaCurdy; Monica Houstoun; Qin Ryan; Sarah Wong; Katrina Mott; Ting-Chang Sheu; Susan Limb; Chris Worrall; Jeffrey A Kelman; Marsha E Reichman
Journal:  JAMA       Date:  2015-11-17       Impact factor: 56.272

Review 7.  Iron requirements in hemodialysis.

Authors:  John A Sargent; Sergio R Acchiardo
Journal:  Blood Purif       Date:  2004       Impact factor: 2.614

8.  The comparative short-term effectiveness of iron dosing and formulations in US hemodialysis patients.

Authors:  Abhijit V Kshirsagar; Janet K Freburger; Alan R Ellis; Lily Wang; Wolfgang C Winkelmayer; M Alan Brookhart
Journal:  Am J Med       Date:  2013-04-15       Impact factor: 4.965

9.  Comparative Effectiveness of Iron and Erythropoiesis-Stimulating Agent Dosing on Health-Related Quality of Life in Patients Receiving Hemodialysis.

Authors:  Janet K Freburger; Alan R Ellis; Lily Wang; Anne M Butler; Abhijit V Kshirsagar; Wolfgang C Winkelmayer; M Alan Brookhart
Journal:  Am J Kidney Dis       Date:  2015-10-23       Impact factor: 8.860
  9 in total
  2 in total

1.  Safety of Dynamic Intravenous Iron Administration Strategies in Hemodialysis Patients.

Authors:  Xiaojuan Li; Stephen R Cole; Abhijit V Kshirsagar; Jason P Fine; Til Stürmer; M Alan Brookhart
Journal:  Clin J Am Soc Nephrol       Date:  2019-04-15       Impact factor: 8.237

2.  Randomized Trial Comparing Proactive, High-Dose versus Reactive, Low-Dose Intravenous Iron Supplementation in Hemodialysis (PIVOTAL): Study Design and Baseline Data.

Authors:  Iain C Macdougall; Claire White; Stefan D Anker; Sunil Bhandari; Kenneth Farrington; Philip A Kalra; John J V McMurray; Heather Murray; Retha Steenkamp; Charles R V Tomson; David C Wheeler; Christopher G Winearls; Ian Ford
Journal:  Am J Nephrol       Date:  2018-10-10       Impact factor: 3.754
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.